Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Diagnostics

Diagnostics Histology

Case of the Month

Can you determine the hereditary syndrome that this renal tumor is indicative of?

Diagnostics Genetics and epigenetics

Scrutinizing Breast Cancer

| Michael Schubert

The FLEX breast cancer registry intends to collect complete information on 10,000 patients over the course of 10 years

Diagnostics Biochemistry and molecular biology

Treat or Surveil

| George Vasmatzis and John Cheville

Newly discovered genetic alterations could indicate whether treatment or active surveillance is the best option for low-risk prostate cancer patients

Diagnostics Clinical care

MDLUX2: Drawing a Fuller Picture

| Michael Schubert

Luxembourg’s new molecular diagnostics program aims to establish the value of such analyses as a part of routine cancer care

Diagnostics Biochemistry and molecular biology

One TINY Step at a Time

| Michael Schubert

For regions with limited infrastructure, a device that can diagnose Kaposi’s sarcoma without the need for a steady power supply could be invaluable

Diagnostics Analytical science

An Analytical Pill

| Michael Schubert

An electronic gas-sensing capsule may increase diagnostic and monitoring accuracy in disorders of the digestive tract

Diagnostics Histology

Case of the Month

Can you diagnose this testicular mass and decide which histologic finding incurs the worst prognosis?

Diagnostics Genetics and epigenetics

Biomarkers on the Brain

| Steve Clifford

A newly discovered chromosome signature offers hope to children with medulloblastoma who may not need intense therapy

Diagnostics Point of care testing

Smarter, Faster Sepsis Testing

| David Ludvigson

A two-stage model featuring point of care sepsis testing and follow-up lab results could improve treatment and reduce the risk of mortality

Diagnostics Genetics and epigenetics

The Evolution of Epigenetic Biomarkers

| Niamh Buckley, Laura Feeney, James Beirne, and Paul Mullan

Markers such as DNA methylation, analyzed by liquid biopsy, may improve on ovarian cancer testing options like gold standard CA125

Newsletter

Send me the latest from The Pathologist.

Sign up now

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register